Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crowdstrike Holdings Inc (CRWD) vs Health Care Select Sector SPDR Fund (XLV) Price & Performance

Crowdstrike Holdings IncTrade
Health Care Select Sector SPDR FundTrade

Price performance (Past 24H)

Key statistics

Crowdstrike Holdings Inc vs Health Care Select Sector SPDR Fund — how do they compare? Crowdstrike Holdings Inc trades at $275.26 (market cap $269.31B), while Health Care Select Sector SPDR Fund trades at $170.81 (market cap $43.48B). The key difference: Crowdstrike Holdings Inc is far larger — about 6.2× Health Care Select Sector SPDR Fund's market cap, and Crowdstrike Holdings Inc is trading nearer its 52-week high, Health Care Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Crowdstrike Holdings Inc for 97 Days and Health Care Select Sector SPDR Fund for 100 Days on average.

CRWDXLV
Market Cap
$269.31B$43.48B
Volume
9,381,56011,121,431
Sector
Technology—
52-Week High
$278.86$175.68
52-Week Low
$87.56$141.95
Typical Hold Time
97 Days100 Days
Enterprise Value
$265.11B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crowdstrike Holdings Inc

CrowdStrike (CRWD) trades at $275.04, up 3.62% today and near its all-time high, with a bullish technical signal from moving averages. The company shows strong revenue growth, reaching $3.95B in 2025, though net income remains negative at -$19.27M. Recent earnings beats and positive analyst sentiment (76% buy ratings) highlight momentum, while the stock trades at elevated valuation multiples like P/S of 49.86. Key developments include expansion into the OpenAI Marketplace and AI-driven cybersecurity demand.

Outlook: CrowdStrike's growth trajectory and AI positioning offer upside, but high valuations and profitability challenges pose risks. Analyst consensus target is $235.74, below current price, suggesting caution despite bullish sentiment. Competitive pressures and execution on net income conversion are critical for sustained gains.

Health Care Select Sector SPDR Fund

XLV trades at $170.81, up 1.18% with a bearish technical signal from moving averages. The ETF's low 0.08% expense ratio and healthcare sector diversification provide defensive positioning amid market volatility. Recent options activity shows increased put volume, indicating some investor caution despite healthcare's traditional defensive characteristics during economic uncertainty.

Healthcare sector ETFs like XLV offer defensive exposure with potential upside from demographic trends and innovation. Key risks include political volatility around healthcare policy and concentration in large-cap US stocks. The ETF's cost efficiency and sector positioning make it attractive for long-term investors seeking healthcare exposure.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

CRWD
84% Buy16% Sell
Avg holding period · 97 Days
XLV
44% Buy56% Sell
Avg holding period · 100 Days

Top news

Latest headlines on both assets

About Crowdstrike Holdings Inc

CrowdStrike Holdings provides cybersecurity products and services aimed at protecting organizations from cyberthreats. It offers cloud-delivered protection across endpoints, cloud workloads, identity and data, and threat intelligence, managed security services, IT operations management, threat hunting, identity protection, and log management. CrowdStrike went public in 2019 and serves customers worldwide.

Read more on CRWD →

About Health Care Select Sector SPDR Fund

In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.

Read more on XLV →